Cote GM, et al. - Authors executed this study to describe their experience with a targeted next-generation sequencing (NGS) platform in clinic patients. This study described a single-center experience with targeted NGS for patients with sarcoma. As per observations, targeted NGS was a useful tool in potentially routing patients to mutation-specific clinical trials.